DUBLIN, July 19, 2016 /PRNewswire/ --
Research and Markets has announced the addition of the "Global Biotech Partnering Terms and Agreements 2010-2016: Deal trends, players and financials" report to their offering.
Global Biotech Partnering Terms and Agreements 2010 to 2016 report provides a detailed understanding and analysis of how and why companies enter Biotech partnering deals. These deals tend to be multicomponent, starting with collaborative R&D, and proceed to commercialization of outcomes.
The report presents financial deal term values for Biotech deals, listing by headline value, upfront payments, milestone payments and royalties, enabling readers to analyse and benchmark the financial value of deals.
One of the key highlights of the report is that over 7,000 online deal records of actual Biotech deals, as disclosed by the deal parties, are included towards the end of the report in a directory format - by company A-Z, stage of development, deal type, therapy focus, and technology type - that is easy to reference. Each deal record in the report links via Weblink to an online version of the deal.
Key benefits
- In-depth understanding of Biotech deal trends since 2010
- Access to headline, upfront, milestone and royalty data
- Analysis of the structure of Biotech agreements with real life case studies
- Detailed access to actual Biotech contracts entered into by leading biopharma companies
- Identify most active Biotech dealmakers since 2010
- Insight into terms included in a Biotech partnering agreement, with real world examples
- Understand the key deal terms companies have agreed in previous deals
- Undertake due diligence to assess suitability of your proposed deal terms for partner companies
In Global Biotech Partnering 2010-2016: Deal trends, players, financials and forecasts, the available deals are listed by:
- Company A-Z
- Headline value
- Stage of development at signing
- Deal component type
- Specific therapy target
- Technology type
Key Topics Covered:
Executive Summary
Chapter 1 - Introduction
Chapter 2 - Trends in Biotech dealmaking
Chapter 3 - Leading Biotech deals
Chapter 4 - Most active Biotech dealmakers
Chapter 5 - Biotech contracts dealmaking directory
Chapter 6 - Biotech dealmaking by technology type
Chapter 7 - Partnering resource center
For more information visit http://www.researchandmarkets.com/research/vz5tx2/global_biotech
Media Contact:
Research and Markets
Laura Wood, Senior Manager
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
SOURCE Research and Markets
Related Links
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
Newsrooms &
Influencers
Digital Media
Outlets
Journalists
Opted In
Share this article